癌症新陈代谢和癌症发生
Jianqiang Yang1, Chloe Shay2, Nabil F Saba1
1Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Experimental hematology & oncology
|January 30, 2024
概括
癌细胞重编程新陈代谢以生存和适应,显示代谢异质性. 针对这种异质性提供了一个有希望的战略,以克服治疗耐药性和改善患者的结果.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 代谢重编程 代谢重编程
背景情况:
- 代谢重编程是癌症的一个关键标志,使细胞能够满足高能耗需求并适应瘤微环境.
- 癌细胞表现出代谢异质性,利用不同的代谢途径生存,增殖和耐治疗.
- 了解代谢异质性对于开发有效的癌症治疗至关重要.
研究的目的:
- 审查不同癌细胞种群和发育阶段的代谢模式.
- 总结癌症代谢相互作用背后的分子机制.
- 突出针对癌症治疗中的代谢脆弱性的临床潜力.
主要方法:
- 关于癌症代谢研究的文献综述.
- 分析代谢途径及其在癌症中的调节.
- 综合有关代谢异质性及其临床影响的数据.
主要成果:
- 癌细胞表现出显著的代谢可塑性和异质性.
- 代谢途径在癌症生态系统中是复杂的相互连接.
- 针对特定的代谢漏洞可以克服治疗耐药性.
结论:
- 癌症中的代谢异质性是一个重大挑战,同时也是一个治疗机会.
- 针对癌症新陈代谢提供了一种新的策略,以提高治疗效率和患者的治疗结果.
- 针对不同代谢特征的个性化方法对于未来的癌症治疗至关重要.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


